Roche Media News

Roche to present new data at ASCO 2026, reinforcing giredestrant's potential to transform the treatment paradigm in early breast cancer

6 days ago

New giredestrant data from the lidERA study on its potential as a...

Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)

13 days ago

Elecsys® pTau217 is the first blood test for Alzheimer’s disease pathology with...

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

18 days ago

PathAI’s best-in-class Image Management System (IMS) with advanced AI analysis and workflow...

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

25 days ago

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey...

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc

about 1 month ago

Group sales were +6% at constant exchange rates (CER)1, -5% when reported...

Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS

about 1 month ago

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of...

Roche’s ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD

about 1 month ago

Phase III METEOROID study met its primary endpoint in patients with myelin...

FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus

about 1 month ago

Filing acceptance based on phase III ALLEGORY data for Gazyva/Gazyvaro showing a...

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

about 1 month ago

The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in...

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply

about 2 months ago

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV...

https://www.roche.com/media/releases/med-cor-2026-03-23

2 months ago

Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions

2 months ago

With the addition of 2,176 NVIDIA Blackwell GPUs, Roche now operates the...